Sexually transmitted diseases in older adults

  • Margaret-Mary G. Wilson


Health professionals are frequently reluctant to recognize or investigate the sexuality of their older patients. Thus, sexual health may never be addressed, even among older adults who come into frequent contact with health care professionals. As the dominant culture continues to shift toward a more realistic view of aging that supports the expression of sexuality among older adults, evaluation of sexual health will become a critical component of comprehensive assessment of the geriatric patient. This article reviews the clinical features and management of common sexually transmitted diseases in the older adult.


Syphilis Bacterial Vaginosis Chlamydia Trachomatis Genital Herpes Sexually Transmitted Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Carret ML, Fassa AG, da Silveira DS, et al.: [Sexually transmitted diseases symptoms in adults: prevalence and risk factors]. Rev Saude Publica 2004, 38:76–84.PubMedCrossRefGoogle Scholar
  2. 2.
    Xu F, Schillinger JA, Aubin MR, et al.: Sexually transmitted diseases of older persons in Washington State. Sex Transm Dis 2001, 28:287–291. A good overview of the epidemiologic characteristics and presenting features of STDs in older patients.PubMedCrossRefGoogle Scholar
  3. 3.
    Kalter DC, Rosen T: Sexually transmitted diseases. Emerg Med Clin North Am 1985, 3:693–716.PubMedGoogle Scholar
  4. 4.
    Diseker RA III, Peterman TA, Kamb ML, et al.: Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect 2000, 76:474–479.PubMedCrossRefGoogle Scholar
  5. 5.
    Hogben M, Bloom F, McFarlane M, et al.: Factors associated with sexually transmitted disease clinic attendance. Int J Nurs Stud 2004, 41:911–920.PubMedCrossRefGoogle Scholar
  6. 6.
    Reporting of chlamydial infection—Massachusetts, January-June 2003. MMWR Morb Mortal Wkly Rep 2005, 54:558–560.Google Scholar
  7. 7.
    LaMontagne DS, Fine DN, Marrazzo JM: Chlamydia trachomatis infection in asymptomatic men. Am J Prev Med 2003, 24:36–42.PubMedCrossRefGoogle Scholar
  8. 8.
    Karlovsky M, Lebed B, Mydlo JH: Increasing incidence and importance of HIV/AIDS and gonorrhoea among men aged >/= 50 years in the US in the era of erectile dysfunction therapy. Scand J Urol Nephrol 2004, 38:247–252.PubMedCrossRefGoogle Scholar
  9. 9.
    Mark KE, Gunn RA: Gonorrhoea surveillance: estimating epidemiologic and clinical characteristics of reported cases using a sample survey methodology. Sex Transm Dis 2004, 31:215–220.PubMedCrossRefGoogle Scholar
  10. 10.
    McGrath C, Rene A, Jones B, Sandhu R: Descriptive study of sexually transmitted diseases in Tarrant County, Texas, from 1998 through 2000. Tex Med 2003, 99:48–53.PubMedGoogle Scholar
  11. 11.
    Spence MR: Gonorrhoea. Clin Obstet Gynecol 1983, 26:111–124.PubMedCrossRefGoogle Scholar
  12. 12.
    Sanders JW, Hook EW III, Welsh LE, et al.: Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men. J Clin Microbiol 1994, 32:24–27.PubMedGoogle Scholar
  13. 13.
    Brackbill RM, Sternberg MR, Fishbein M: Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999, 31:10–15.PubMedCrossRefGoogle Scholar
  14. 14.
    Stamm WE, Hicks CB, Martin DH, et al.: Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA 1995, 274:545–549.PubMedCrossRefGoogle Scholar
  15. 15.
    Schwebke JR, Burgess D: Trichomoniasis. Clin Microbiol Rev 2004, 17:794–803.PubMedCrossRefGoogle Scholar
  16. 16.
    Soper D: Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 2004, 190:281–290.PubMedCrossRefGoogle Scholar
  17. 17.
    Wendel KA: Trichomoniasis: What’s New? Curr Infect Dis Rep 2003, 5:129–134.PubMedGoogle Scholar
  18. 18.
    Roy K, Wang SA, Meltzer MI: Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae. Emerg Infect Dis 2005, 11:1265–1273.PubMedGoogle Scholar
  19. 19.
    Ghanem KG, Giles JA, Zenilman JM: Fluoroquinoloneresistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 2005, 19:351–365.PubMedCrossRefGoogle Scholar
  20. 20.
    Wiesenfeld HC, Sweet RL, Ness RB, et al.: Comparison of acute and subclinical pelvic inf lammator y disease. Sex Transm Dis 2005, 32:400–405.PubMedCrossRefGoogle Scholar
  21. 21.
    French L, Horton J, Matousek M: Abnormal vaginal discharge: what does and does not work in treating underlying causes. J Fam Pract 2004, 53:890–894. A good review outlining a useful and practical approach to evaluating vaginal discharge in older adults.PubMedGoogle Scholar
  22. 22.
    Kissinger PJ, Dumestre J, Clark R A, et al.: Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis 2005, 32:227–230.PubMedCrossRefGoogle Scholar
  23. 23.
    Swygard H, Miller WC, Kaydos-Daniels SC, et al.: Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis 2004, 31:659–664.PubMedCrossRefGoogle Scholar
  24. 24.
    Price MA, Miller WC, Kaydos-Daniels SC, et al.: Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi. J Infect Dis 2004, 190:1448–1455.PubMedCrossRefGoogle Scholar
  25. 25.
    Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM: Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003, 79:151–153.PubMedCrossRefGoogle Scholar
  26. 26.
    Schwebke JR: Cost-effective screening for trichomoniasis. Emerg Infect Dis 2002, 8:749–750.PubMedGoogle Scholar
  27. 27.
    Schmid G, Narcisi E, Mosure D, et al.: Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001, 46:545–549.PubMedGoogle Scholar
  28. 28.
    Spiliopoulou A, Lakiotis V, Vittoraki A, et al.: Chlamydia trachomatis: time for screening? Clin Microbiol Infect 2005, 11:687–689.PubMedCrossRefGoogle Scholar
  29. 29.
    Bhandari H, Malhotra S, Sharma M, Kumar B: Microbial flora of women with chronic cervicitis. J Indian Med Assoc 2000, 98:384–386.PubMedGoogle Scholar
  30. 30.
    Dybas I, Sidor-Wojtowicz A, Koziol-Montewka M: [Bacterial flora and mycosis of the vagina in women with symptoms of vaginal inflammation]. Ginekol Pol 2005, 76:385–390.PubMedGoogle Scholar
  31. 31.
    Chiaffarino F, Parazzini F, De BP, Lavezzari M: Risk factors for bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 2004, 117:222–226.PubMedCrossRefGoogle Scholar
  32. 32.
    Gonzalez-Pedraza AA, Mota VR, Ortiz ZC, Ponce Rosas RE: [Factors of risk of bacterial vaginosis]. Aten Primaria 2004, 34:360–365.CrossRefGoogle Scholar
  33. 33.
    Luni Y, Munim S, Qureshi R, Tareen AL: Frequency and diagnosis of bacterial vaginosis. J Coll Physicians Surg Pak 2005, 15:270–272.PubMedGoogle Scholar
  34. 34.
    Das S, Sabin C, Allan S: Higher vaginal pH is associated with Chlamydia trachomatis infection in women: a prospective case-controlled study. Int J STD AIDS 2005, 16:290–293.PubMedCrossRefGoogle Scholar
  35. 35.
    Beigi RH, Austin MN, Meyn LA, et al.: Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004, 191:1124–1129.PubMedCrossRefGoogle Scholar
  36. 36.
    Andreeva PM, Omar HA: Effectiveness of current therapy of bacterial vaginosis. Int J Adolesc Med Health 2002, 14:145–148.PubMedGoogle Scholar
  37. 37.
    Celum C, Levine R, Weaver M, Wald A: Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ 2004, 82:447–453.PubMedGoogle Scholar
  38. 38.
    Mertz KJ, Trees D, Levine WC, et al.: Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis 1998, 178:1795–1798.PubMedCrossRefGoogle Scholar
  39. 39.
    Leone P: Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Curr Med Res Opin 2005, 21:1577–1582.PubMedCrossRefGoogle Scholar
  40. 40.
    Guirguis-Blake J, Wolff TA: Screening for genital herpes. Am Fam Physician 2005, 72:135–136.PubMedGoogle Scholar
  41. 41.
    Baldwin HE: STD update: screening and therapeutic options. Int J Fertil Womens Med 2001, 46:79–88.PubMedGoogle Scholar
  42. 42.
    Brown TJ, Yen-Moore A, Tyring SK: An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 1999, 41:511–532.PubMedGoogle Scholar
  43. 43.
    Inelman EM, Gasparini G, Enzi G: HIV/AIDS in older adults: a case report and literature review. Geriatrics 2005, 60:26–30. An excellent overview of the epidemiologic characteristics and clinical features of HIV/AIDS in the geriatric population.PubMedGoogle Scholar
  44. 44.
    Kahn RH, Moseley KE, Thilges JN, et al.: Community-based screening and treatment for STDs: results from a mobile clinic initiative. Sex Transm Dis 2003, 30:654–658.PubMedCrossRefGoogle Scholar
  45. 45.
    Caudie C, Garel F, Bancel J, et al.: [Diagnosis and biological monitoring of 6 neurosyphilis cases: value of cerebrospinal fluid analysis]. Ann Biol Clin (Paris) 2003, 61:563–569.Google Scholar
  46. 46.
    Polsky I, Samuels SC: Neurosyphilis. Screening does sometimes reveal an infectious cause of dementia. Geriatrics 2001, 56:60–62.PubMedGoogle Scholar
  47. 47.
    Augenbraun M: Treatment of latent and tertiary syphilis. Hosp Pract (Off Ed) 2000, 35:89–95.Google Scholar
  48. 48.
    Inelman EM, Gasparini G, Enzi G: HIV/AIDS in older adults: a case report and literature review. Geriatrics 2005, 60:26–30.PubMedGoogle Scholar
  49. 49.
    Wachter KW, Knodel JE, Vanlandingham M: AIDS and the elderly of Thailand: projecting familial impacts. Demography 2002, 39:25–41.PubMedGoogle Scholar
  50. 50.
    Kalichman SC, Heckman T, Kochman A: Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv 2000, 51:903–907.PubMedCrossRefGoogle Scholar
  51. 51.
    Blacker J: The impact of AIDS on adult mortality: evidence from national and regional statistics. AIDS 2004, 18(Suppl 2):S19-S26.PubMedCrossRefGoogle Scholar
  52. 52.
    Gaeta TJ, LaPolla C, Melendez E: AIDS in the elderly: New York City vital statistics. J Emerg Med 1996, 14:19–23.PubMedCrossRefGoogle Scholar
  53. 53.
    Cury PM, Pulido CF, Furtado VM, da Palma FM: Autopsy findings in AIDS patients from a reference hospital in Brazil: analysis of 92 cases. Pathol Res Pract 2003, 199:811–814.PubMedCrossRefGoogle Scholar
  54. 54.
    Babiker A, Darbyshire J, Pezzotti P, et al.: Changes over calendar time in the risk of specific first AIDS-de.ning events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol 2002, 31:951–958.PubMedCrossRefGoogle Scholar
  55. 55.
    Walsh K, Thompson W, Megyesi J, et al.: HIV-1/AIDS neuropathology in a Canadian teaching centre. Can J Neurol Sci 2004, 31:235–241.PubMedGoogle Scholar
  56. 56.
    Welch K, Morse A: The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy. AIDS Patient Care STDS 2002, 16:75–81.PubMedCrossRefGoogle Scholar
  57. 57.
    Aceto L, Karrer U, Grube Ch, et al.: [Primary HIV-1 infection in Zurich: 2002–2004]. Schweiz Rundsch Me. Prax 2005, 94:1199–1205.Google Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of Geriatric MedicineSt Louis University Health Sciences CenterSt. LouisUSA

Personalised recommendations